Spine

DFine launches tumor ‘melting’ trial

June 11, 2014 by Arezu Sarvestani

DFine Inc. begins enrolling patients in a clinical trial of its STAR tumor ablation system, designed to “melt” tumors with radiofrequency energy.

Spinal therapies maker DFine Inc. launched enrollment in a clinical trial of its STAR tumor ablation system, evaluating the technology in treatment of spinal tumors.

The new EU-STAR clinical trial will enroll 40 patients at 5 centers in Germany and France, DFine reported. Researchers are looking to examine patients’ pain from 1 month following the procedure out to 6 months, as well as patients’ function, quality of life and reliance on pain medications.

READ THE REST AT MASSDEVICE

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button